MM02-35
A Phase II Study of Bisphosphonate: Zoledronic Acid (Zometa) in the Management of Asymptomatic/Early Stage Multiple Myeloma
A Phase II Study of Bisphosphonate: Zoledronic Acid (Zometa) in the Management of Asymptomatic/Early Stage Multiple Myeloma
© 2024 Hoosier Cancer Research Network | 7676 Interactive Way, Suite 120 · Indianapolis, IN 46278 | (317) 921-2050 | contact@hoosiercancer.org | Terms of Use | Privacy Policy | Sitemap
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter